Emiko Sakaida¹, Jun Takiguchi¹, Chikako Ohwada¹, Takaaki Tanami¹, Yasuhito Hatanaka¹, Arata Ishii¹, Miki Yamazaki¹, Yurie Nagai¹, Tatsuzo Mishina¹, Yutaro Hino¹, Koji Takaishi¹, Yusuke Isshiki¹, Kenji Kimura¹, Kensuke Kayamori¹, Nagisa Oshima¹, Shokichi Tsukamoto¹, Shio Mitsukawa^1,2, Yusuke Takeda¹, Naoya Mimura^1,2, Masahiro Takeuchi¹, Tohru Iseki^1,2, Chiaki Nakaseko^1,3 (1.Department of Hematology, Chiba University Hospital, 2.Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, 3.Department of Hematology, International University of Health and Welfare, Narita)

Haruko Shima¹, Akihiko Tanizawa¹, Hidemitsu Kurosawa¹, Akihiro Watanabe¹, Masaki Ito¹, Chikako Tono¹, Yuki Yuza¹, Hideki Muramatsu¹, Kazuko Hamamoto¹, Masahiko Okada¹, Koji Kato², Kimikazu Matsumoto³, Norio Shiba⁴, Hiroyuki Shimada¹ (1.JCCG, CML committee, 2.Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 3.Children's Cancer Center, NCCHD, Tokyo, Japan, 4.Dept. Pediatrics, Yokohama City University Hospital, Kanagawa, Japan)

Isao Fujioka¹, Tomoiku Takaku¹, Michihide Tokuhira², Yuta Kimura², Eisaku Iwanaga³, Keiji Sugimoto⁴, Tomonori Nakazato⁵, Noriyoshi Iriyama⁶, Eriko Sato⁷, Maho Ishikawa⁸, Hiroyuki Fujita⁹, Norio Asou⁸, Yoshihiro Hatta⁶, Masahiro Kizaki², Norio Komatsu¹, Tatsuya Kawaguchi¹⁰ (1.Dept. Hematology, Juntendo University School of Medicine, Tokyo, Japan, 2.Dept. Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan, 3.Dept. Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan, 4.Dept. Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan, 5.Dept. Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 6.Div. Hematology & Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 7.Div. Hematology, Dept. Medicine, Juntendo University Nerima Hospital, Tokyo,, 8.Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, 9.Dept. Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 10.Kumamoto Health Science University, Kumamoto, Japan)

Maho Ishikawa¹, Noriyoshi Iriyama², Michihide Tokuhira³, Tomoiku Takaku⁴, Eriko Sato⁵, Keiji Sugimoto⁶, Tomonori Nakazato⁷, Eisaku Iwanaga⁸, Hiroyuki Fujita⁹, Yuta Kimura³, Isao Fujioka⁴, Norio Komatsu⁴, Norio Asou¹, Masahiro Kizaki³, Yoshihiro Hatta², Tatsuya Kawaguchi¹⁰ (1.Dept. Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan., 2.Division of Hematology and Rheumatology, Nihon University, Tokyo, Japan, 3.Dept. Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan, 4.Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan, 5.Division of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan, 6.Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan, 7.Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 8.Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan, 9.Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 10.Kumamoto Health Science University, Kumamoto, Japan)

Kiyohiko Hatake^1,2,3,4,5, Takahiro Yoshida², Moriyoshi Yasuda³, Mihoko Ota³, Akira Masunari³, Yasuhiko Fukuta³, Yuji Ikari⁴, Arinobu Tojo⁵ (1.Hematology, International University of Health and Welfare,Tokyo, Japan, 2.Medical Affairs, Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan, 3.Pharmacovigilance, Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan, 4.Tokai University School of Medicine, Kanagawa, Japan, 5.The Institute of Medical Science, The University of Tokyo, Japan)

Charles Chuah¹, Liang Piu Koh², Tontanai Numbenjapon³, Dae Young Zang⁴, Kiat Hoe Ong⁵, Young Rok Do⁶, Eric Leip⁷, Chiho Ono⁸, Rocco Crescenzo⁹, Jorge Cortes¹⁰, Tim Brümmendorf¹¹, Carlo Gambacorti-Passerini¹², Michael Deininger¹³, Michael Mauro¹⁴, Andreas Hochhaus¹⁵, Dong-Wook Kim¹⁶ (1.Singapore General Hospital, Duke-NUS Medical School, Singapore, Republic of Singapore, 2.National University Cancer Institute, Singapore, Republic of Singapore, 3.Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Kingdom of Thailand, 4.Hallym University Sacred Heart Hospital, Anyang, Republic of Korea, 5.Tan Tock Seng Hospital, Singapore, Republic of Singapore, 6.Keimyung University, Daegu, Republic of Korea, 7.Pfizer Inc, Cambridge, United States of America, 8.Pfizer Japan Inc, Tokyo, Japan, 9.Pfizer Inc, Collegeville, United States of America, 10.University of Texas MD Anderson Cancer Center, Houston, United States of America, 11.Universitätsklinikum RWTH Aachen, Aachen, Federal Republic of Germany, 12.University of Milano-Bicocca, San Gerardo Hospital, Monza, Italian Republic, 13.University of Utah, Salt Lake City, United States of America, 14.Memorial Sloan Kettering Cancer Center, New York, United States of America, 15.Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Federal Republic of Germany, 16.Seoul St. Mary's Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, Republic of Korea)